Outlook Therapeutics, Inc. (OTLK) Social Stream



Outlook Therapeutics, Inc. (OTLK): $1.20

0.05 (+4.35%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add OTLK to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

Outlook Therapeutics Inc (OTLK) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering OTLK.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-02-15 2 $8 $6 $7 $1.85 278.38%

The Trend in the Analyst Price Target


OTLK's average price target has moved up $1.67 over the prior 32 weeks.

OTLK reports an average of 195.3% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-02 4 6 5 5.33 2.71 96.68%
2021-08-14 4 8 6 6.67 2.40 177.92%
2021-09-11 4 8 6 7.00 2.49 181.12%
2021-12-23 2 8 6 7.00 1.38 407.25%
2022-02-15 2 8 6 7.00 1.40 400%

OTLK Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


Over the past 62 days, OTLK's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of Healthcare stocks, Outlook Therapeutics Inc's number of analysts covering the stock is greater than 4.69% of them.
  • Outlook Therapeutics Inc's average analyst price target is higher than 10.17% of Healthcare stocks.
  • In the context of stocks in the small market cap category, Outlook Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 78.06% of them.
  • In terms of how Outlook Therapeutics Inc fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 77.79% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Outlook Therapeutics Inc are OPT, ONVO, and OMGA.

Is OTLK a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.0351 seconds.